Edition:
United States

Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

53.10TWD
23 May 2017
Change (% chg)

NT$-0.40 (-0.75%)
Prev Close
NT$53.50
Open
NT$54.00
Day's High
NT$54.20
Day's Low
NT$53.10
Volume
163
Avg. Vol
472,517
52-wk High
NT$93.40
52-wk Low
NT$52.20

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

Shizhong Zhang

2007 Chairman of the Board

Yuren Zheng

2010 General Manager, Director

Chaoquan Ou

2011 Deputy General Manager-Finance and Accounting Management

Guanlang Lai

2005 Deputy General Manager-New Drug Development

Ziliang Huang

2001 Director